Brand VerifiedChina

Beijing LabTech Instruments Co., Ltd.

LabTech

Beijing LabTech Instruments Co., Ltd., which sells under the LabTech brand, is a Chinese manufacturer of laboratory analytical instruments and sample-preparation equipment based in the Tianzhu Airport Industrial Zone in Beijing's Shunyi District. It was founded in 2002 and listed on the Shanghai Stock Exchange STAR Market on 2 September 2020 at RMB 24.80 per share under ticker 688056. The business is analytical instrumentation, not education hardware: it builds instruments that digest, extract, purify, separate and measure samples for environmental monitoring, food and agricultural testing, pharmaceutical quality control and semiconductor analysis. Total operating revenue for the 2025 financial year was RMB 401.08 million, down 5.41 percent year on year, while net profit attributable to shareholders rose 3.19 percent to RMB 40.40 million and non-recurring-adjusted net profit rose 10.25 percent to RMB 34.14 million. R&D spending reached RMB 48.54 million, 12.10 percent of revenue. Overseas sales grew 22.17 percent to RMB 78.54 million, 19.72 percent of main-business revenue. In the first half of 2026 revenue was RMB 189.90 million, down 1.07 percent, with net profit attributable to shareholders down 36.60 percent to RMB 13.37 million even though second-quarter revenue rose 11.01 percent. The product range is broad and instrument-led. LabTech's flagship analytical line is its inductively coupled plasma mass spectrometry family, the LabMS 3000, LabMS 3300 and triple-quadrupole LabMS 5000 ICP-MS/MS, joined by ICP-OES, atomic absorption and atomic fluorescence spectrometers. Around those sit a deep sample-preparation portfolio: the REVO microwave digestion line, graphite digestion, automated solid-phase extraction, accelerated solvent and pressure extraction, GPC1000 gel permeation clean-up, automated concentration, the PT3000 purge-and-trap and PY1000 pyrolysis instruments, and consumables sold under the CDS and Empore names. VerityRank places LabTech in the Top 10 Educational Laboratory Instruments Brands because universities and research institutes are a real, growing and disclosed customer group. The company's 2025 annual report states that research institutes and universities and colleges generated RMB 37.96 million, or 9.53 percent of main-business revenue and 9.46 percent of total revenue, up 35.35 percent year on year. That is far smaller than the education specialists on this page, and LabTech is not an education-first company. The frequently cited claim that teaching and research laboratories account for about 35 percent of turnover is a misreading of the segment's 35.35 percent growth rate. Manufacturing is genuinely in-house, with production in Beijing and Tianjin supplemented by LabTech, Inc. in Hopkinton, Massachusetts and CDS Analytical, LLC in Oxford, Pennsylvania, whose pyrolysis and thermal desorption instruments descend from equipment used for ground-reference work on NASA's Mars Curiosity sample-analysis module. The group owns the LabTech, CDS and Empore brands and held 162 granted patents and 83 software copyrights at the end of 2025. LabTech's principal risks are profitability under investment and a share price detached from its fundamentals. Research intensity is climbing faster than revenue, and the company has twice published severe-abnormality notices after sharp rises driven by semiconductor-themed speculation, in June and September 2026, noting that semiconductor-related revenue remains under 2 percent of turnover and that all ICP-MS sales were only 8.03 percent of revenue in 2025.

Business Nature

LabTech designs and builds its own instruments rather than rebadging imports. Manufacturing is split between China and the United States: the Beijing plant in the Tianzhu Airport Industrial Zone carries instrument production and the research centre, while the wholly owned LabTech Tianjin Technology Co., Ltd. base in Baodi District, Tianjin, opened in May 2023 and takes on part of the production load. Two United States subsidiaries complete the chain, LabTech, Inc. in Hopkinton, Massachusetts and CDS Analytical, LLC at Oxford, Pennsylvania, which builds pyrolysis, thermal desorption and purge-and-trap instruments. The company runs a combined matrix and project research model and sells mainly direct to end users, with distributors as a supplement. Its clean-laboratory division designs and installs complete laboratory environments. Headcount was 526 at end-2025, 135 of them in research and development. Production is built to order. The company made 6,017 instrument sets in 2025 and its ICP-MS line runs with no inventory build; no annual capacity figure is disclosed, so the claim of more than 15,000 units a year is unverified. Purchasing is international where it matters, with Milestone SRL of Italy a named major supplier of microwave chemistry instruments.

Core Business Areas

Sample Preparation – core franchise and highest-volume line
• REVO microwave digestion and graphite digestion systems
• Automated solid-phase extraction SPE1000PLUS, AutoEmpore and Empore membranes
• Accelerated solvent and pressure extraction FlexHPSE and GPC1000 gel permeation clean-up

Elemental & Molecular Analysis – the high-value growth line
• LabMS 5000 triple-quadrupole ICP-MS/MS, plus LabMS 3000 and LabMS 3300 ICP-MS
• LabICP 1000 and LabICP 2000 ICP-OES, LabAA 2000 atomic absorption
• EvoLab intelligent full-process elemental analysis system

Thermal Analysis & Consumables – made by CDS Analytical in the United States
• PT3000 purge-and-trap and PY1000 and CDS 6200 pyrolysis and thermal desorption
• CDS and Empore consumables, plus the EmporeOmics automation platform

Clean Laboratory Solutions – engineering and fit-out business
• Clean and ultra-clean chemistry laboratories
• Laboratory ventilation, gas supply and pure water systems

Industry Rankings

10Top 10 Educational Laboratory Instruments Brands

Brand

—Top 10 Car Diagnostic Equipment Manufacturers

Mfr

—Top 10 Car Diagnostic Equipment Brands

Brand

—Top 10 Power & Electronic Instruments Manufacturers

Mfr

—Top 10 Power & Electronic Instruments Brands

Brand

Corporate Report

Beijing LabTech Instruments Co., Ltd. is a Chinese analytical-instrument manufacturer based in Beijing's Shunyi District, listed on the Shanghai Stock Exchange STAR Market under ticker 688056 since September 2020 and founded in 2002. VerityRank places it in the Top 10 Educational Laboratory Instruments Brands on the strength of a disclosed and fast-growing university and research-institute customer group, while noting that its revenue comes overwhelmingly from analytical instrumentation rather than from education.

Industry Position

LabTech is a sample-preparation and elemental-analysis specialist rather than a classroom supplier. Its franchise is automating the front end of laboratory analysis: microwave and graphite digestion, accelerated solvent extraction, automated solid-phase extraction, gel permeation chromatography clean-up, purge-and-trap, thermal desorption and pyrolysis. Its 2025 annual report records total operating revenue of RMB 401.08 million, down 5.41 percent, with net profit attributable to shareholders of RMB 40.40 million, up 3.19 percent.

The analytical instrument line is where the company has pushed hardest. Its LabMS 5000 triple-quadrupole ICP-MS/MS and its LabMS 3000 and LabMS 3300 ICP-MS instruments are sold into semiconductor materials analysis, and the company reported ICP-MS sales of RMB 32.20 million, 8.03 percent of revenue, in 2025. In the first half of 2026 analytical instruments produced 79.87 percent of main-business revenue, consumables and service 13.59 percent, and clean-laboratory solutions 6.54 percent.

Competitive Advantages

The advantage is vertical integration in a niche where imports still lead. LabTech designs, builds and sells its own instruments from plants in Beijing and Tianjin and from two United States subsidiaries, LabTech, Inc. in Massachusetts and CDS Analytical, LLC in Pennsylvania, and keeps software and service in-house. Research spending was RMB 48.54 million in 2025, 12.10 percent of revenue, and rose to 14.34 percent in the first half of 2026.

Its consumables and intellectual property add stickiness. The group owns the LabTech, CDS and Empore brands, and the CDS pyrolysis line traces back to instruments used for ground-reference work on NASA's Mars Curiosity sample-analysis module, for which the company still provides technical support. At the end of 2025 it held 162 granted patents and 83 software copyrights.

Strategic Expansion

Growth is being directed at higher-value instruments and at export markets. The company launched the EvoLab intelligent full-process elemental analysis system and the Genesis M1 microplastics analysis system in May 2026, and an EmporeOmics automation platform in August 2026, moving from standalone instruments toward integrated workflows. Overseas revenue reached RMB 78.54 million in 2025, 19.72 percent of main-business revenue and up 22.17 percent year on year.

That export push is deliberate. LabTech exhibited at Pittcon in Boston, analytica in Germany, KOREA LAB in Seoul, LabAsia in Kuala Lumpur, ARABLAB in Dubai, and at ASMS and PYRO in 2026, and it treats Southeast Asia and the Middle East as priority regions. It retained its national specialised and innovative enterprise status in 2025, opened a roughly 1,000 square metre application research centre in September 2026, and made no acquisitions in 2025 or the first half of 2026.

Risks & Outlook

The first correction concerns the education claim itself. The source document asserts that teaching and research laboratories are about 35 percent of revenue; the audited figure is 9.53 percent of main-business revenue, and 35.35 is the segment's growth rate rather than its share. The same document states 2025 revenue of RMB 410 million against an audited RMB 401.08 million, and 85 percent domestic revenue against an actual 80.28 percent. LabTech is an instrument maker that universities buy from, not an education specialist.

The second is profitability and valuation risk. First-half 2026 net profit attributable to shareholders fell 36.60 percent to RMB 13.37 million while R&D intensity rose, and the company has twice issued severe-abnormality notices after semiconductor-themed speculative rallies, in June and September 2026, stressing that semiconductor-related revenue is under 2 percent of turnover. Against competitors including Thermo Fisher, Agilent and Shimadzu, VerityRank Score of 81/100.

VerityRank Score

81/ 100

Based on market presence, financial scale, operational capacity, and brand strength.

Quick Facts

Headquarters

Beijing, Shunyi District, China

Founded

2002

Employees

526 at 31 December 2025 (267 at the parent company and 259 across the main subsidiaries), rising to 528 at 30 June 2026; 135 of those are research and development staff

Revenue

RMB 401.08 million total operating revenue for fiscal year 2025 (audited and company-reported, down 5.41 percent year on year), with net profit attributable to shareholders of RMB 40.40 million, up 3.19 percent; the company reports in renminbi and VerityRank has not converted the figure

Factories

LabTech manufactures in China and the United States through its Beijing plant in Shunyi District where instrument production and the research centre sit, its wholly owned LabTech (Tianjin) Technology Co., Ltd. base in the Jing-Jin Zhongguancun Science City in Baodi District, Tianjin, and two United States subsidiaries, LabTech, Inc. in Hopkinton, Massachusetts and CDS Analytical, LLC at Oxford, Pennsylvania, which builds pyrolysis, thermal desorption and purge-and-trap instruments.

Listing

Listed on the Shanghai Stock Exchange STAR Market since September 2020 under ticker 688056

Data Sources & Methodology

This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.

VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.

Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.

Key references: Official Website , LabTech Official Site · FY2025 Annual Report (SSE Filing) · H1 2026 Report Summary · SSE Company Profile 688056 · Tianjin Manufacturing Base · CDS Analytical (LabTech USA)

Back to Rankings